Jose C. Florez, M.D., Ph.D. is the Chief of the Diabetes Unit at the Massachusetts General Hospital, a Professor at Harvard Medical School, and an Institute Member at the Broad Institute.  He and his group have contributed to the performance and analysis of high-throughput genomic studies in type 2 diabetes and related traits, in international consortia such as MAGIC, GENIE, DIAGRAM, T2D-GENES and SIGMA. He leads the genetic research efforts of the Diabetes Prevention Program, and is the Principal Investigator of the Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans (SUGAR-MGH). In addition to his research and teaching duties, he is clinically active, serves on several Editorial Boards and has received numerous professional awards.